Dietary supplements for obesity
- PMID: 36479472
- PMCID: PMC9710396
- DOI: 10.15167/2421-4248/jpmh2022.63.2S3.2757
Dietary supplements for obesity
Abstract
Obesity and associated complications including diabetes, cardiometabolic dysfunction, disability, malignancy and premature mortality are considered epidemic. Research on obesity is therefore of worldwide importance. The development of obesity is a multifactorial phenomenon with contributions from biological, behavioral, genetic and environmental factors. Obesity and its associated issues require various lifestyle modifications and treatment options such medication, exercise, diet, surgery, pharmacological therapy and dietary supplements. Dietary supplements are considered an attractive alternative to traditional therapy due to their low toxicity profile and their accessibility to the general population. Dietary supplements may include one or more dietary ingredients. In this narrative review, we analyze the effects on obesity and obesity-related issues of various natural components. For example, there are a myriad of supplements that have been used as dietary supplements for weight loss such as minerals, vitamins, amino acids, metabolites, herbs, and plant extracts. This narrative review aims to present the benefits and side-effects of several ingredients of dietary supplements for weight loss and treatment of obesity. In particular, the mechanism of action, results of clinical trials, and possible side effects will be presented for the following ingredients: β-Glucans, bitter orange, calcium, vitamin D, chitosan, chromium, cocoa, coleus forskohlii, conjugate linoleic acid, ephedra sinica, fucoxanthin, garcinia cambogia, glucomannan, green coffee, green tea, guar gum, raspberry, hoodia gordonii, irvingia gabonensis, phenylpropylamine, pyruvate, white kidney bean.
Keywords: Dietary supplements; Nutritional disease; Obesity; Weight loss.
©2022 Pacini Editore SRL, Pisa, Italy.
Similar articles
-
New Dietary Supplements for Obesity: What We Currently Know.Curr Obes Rep. 2016 Jun;5(2):262-70. doi: 10.1007/s13679-016-0214-y. Curr Obes Rep. 2016. PMID: 27053066 Review.
-
The safety and effectiveness of commonly-marketed natural supplements for weight loss in populations with obesity: A critical review of the literature from 2006 to 2016.Crit Rev Food Sci Nutr. 2020;60(10):1614-1630. doi: 10.1080/10408398.2019.1584873. Epub 2019 Mar 21. Crit Rev Food Sci Nutr. 2020. PMID: 30896252 Review.
-
Dietary supplements for body-weight reduction: a systematic review.Am J Clin Nutr. 2004 Apr;79(4):529-36. doi: 10.1093/ajcn/79.4.529. Am J Clin Nutr. 2004. PMID: 15051593 Review.
-
Common dietary supplements for weight loss.Am Fam Physician. 2004 Nov 1;70(9):1731-8. Am Fam Physician. 2004. PMID: 15554492 Review.
-
Dietary supplements in therapy to support weight reduction in obese patients.Acta Sci Pol Technol Aliment. 2022 Jan-Mar;21(1):67-80. doi: 10.17306/J.AFS.1010. Acta Sci Pol Technol Aliment. 2022. PMID: 35174689 Review.
Cited by
-
Novel Therapeutic Approach for Obesity: Seaweeds as an Alternative Medicine with the Latest Conventional Therapy.Med Sci (Basel). 2024 Oct 13;12(4):55. doi: 10.3390/medsci12040055. Med Sci (Basel). 2024. PMID: 39449411 Free PMC article. Review.
-
The Effects of Propolis Consumption on Body Composition and Blood Pressure: A Systematic Review and Dose-Response Meta-Analysis.Curr Ther Res Clin Exp. 2024 Jul 25;101:100754. doi: 10.1016/j.curtheres.2024.100754. eCollection 2024. Curr Ther Res Clin Exp. 2024. PMID: 39247130 Free PMC article. Review.
-
Cancer Prevention and Treatment Based on Lifestyles.Cancer Treat Res. 2024;191:245-279. doi: 10.1007/978-3-031-55622-7_10. Cancer Treat Res. 2024. PMID: 39133411 Review.
-
Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind Study.Biomedicines. 2024 Jul 20;12(7):1620. doi: 10.3390/biomedicines12071620. Biomedicines. 2024. PMID: 39062193 Free PMC article.
-
Identifying the Multitarget Pharmacological Mechanism of Action of Genistein on Lung Cancer by Integrating Network Pharmacology and Molecular Dynamic Simulation.Molecules. 2024 Apr 23;29(9):1913. doi: 10.3390/molecules29091913. Molecules. 2024. PMID: 38731403 Free PMC article.
References
-
- Oppert JM. Obesity: Epidemiology, Pathophysiology and Extra-Respiratory Complications. Rev Pneumol Clin 2002;58:63-70. - PubMed
-
- Vettori A, Paolacci S, Maltese PE, Herbst KL, Cestari M, Michelini S, Michelini S, Samaja M, Bertelli M. Genetic determinants of the effects of training on muscle and adipose tissue homeostasis in obesity associated with lymphedema. Lymphat Res Biol 2021;19:322-33. https://doi.org/10.1089/lrb.2020.0057 10.1089/lrb.2020.0057 - DOI - PubMed
-
- Vettori A, Pompucci G, Paolini B, del Ciondolo I, Bressan S, Dundar M, Kenanoğlu S, Unfer V, Bertelli M. Geneob Project genetic background, nutrition and obesity: a review. Eur Rev Med Pharmacol Sci 2019;23:1751-61. https://doi.org/10.26355/eurrev_201902_17137 10.26355/eurrev_201902_17137 - DOI - PubMed
-
- Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser 2000;894:1-253. - PubMed
-
- Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan G, Bertelli M, Fanin E, Andrighetto G, Federspil G, Vettor R. Increased serum resistin in adults with Prader-Willi Syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005;90:4335-40. https://doi.org/10.1210/jc.2005-0293 10.1210/jc.2005-0293 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical